entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 22:05:37 - browse：931

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Police still searching for prisoner who escaped from NYC hospital

focus

WSS

Carbon Health diabetes program, a test of data

Medicare’s new pay boost for primary care is angering specialists

Ventyx halts psoriasis drug development after lackluster trial results

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

A letter from the executive editor: STAT UnitedHealth investigation

What is STAT's opinion section for?

explore

entertainment

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Heart attack and stroke risk calculators need revising

In same hospitals, Black patients receive fewer opioids than white patients

Supreme Court strikes down use of affirmative action

Experimental asthma app from Apple and Anthem shows promise

Heart attack and stroke risk calculators need revising

Ventyx halts psoriasis drug development after lackluster trial results

At least 13 dead in Texas as scorching temps continue

In same hospitals, Black patients receive fewer opioids than white patients

focus

The best solution to the drug shortages problem

NIH chief: government has fallen behind pharma on clinical trials

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Weight loss drugs should be covered by insurers, AMA says

Emergent cuts jobs, executive role in business shake

focus

focus

focus

hotspot